[144] Cartesian Therapeutics, Inc. SEC Filing
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC submitted a Form 144 notice concerning proposed sales of Common stock tied to restricted stock vesting under a registered plan. The excerpt lists proposed sale entries with dates 01/02/2025 and 01/02/2026, and a filing-related date of 06/02/2026.
The notice identifies amounts and line items such as 3924, 1,235, and 2,689 associated with the vesting entries; the filing shows the broker name and NASDAQ as the market. Timing and cash‑flow treatment for any transactions are not specified in the provided excerpt.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed resale of vested restricted stock under a registered plan.
The excerpt shows restricted stock vesting events dated 01/02/2025 and 01/02/2026 with associated numeric line items. Form 144 is a notice of intent to sell; it does not itself effect a sale.
Settlement mechanics and proceeds recipients are not detailed in the excerpt; subsequent filings or broker disclosures would show actual transactions and cashflow.
Entries appear tied to compensation vesting rather than open-market purchases.
The document labels the securities as "Restricted stock vesting under a registered plan" and lists service-vesting dates with numeric entries (e.g., 01/02/2025, 01/02/2026). That indicates compensation origin of the shares.
Whether shares are sold or retained after vesting depends on the holder; the provided excerpt does not show sale quantities executed or net proceeds.